We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fujirebio Diagnostics Announces Initiation of Clinical Testing for SARS CoV-2 Antigen Assay

Product News   Aug 05, 2020

 
Fujirebio Diagnostics Announces Initiation of Clinical Testing for SARS CoV-2 Antigen Assay

Credit: KUTTHALEEYO/rawpixel

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Bio-Rad Introduces StarBright Violet 515 Dye for Flow Cytometry

Product News

StarBright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols.

READ MORE

Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

Product News

Avacta has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.

READ MORE

Next-Generation Remote Monitoring Solution to Support Optimal Sample Safety and Integrity

Product News

Biotechnology, pharmaceutical, clinical and academic laboratories can now benefit from a next-generation remote monitoring solution designed to enable superior levels of sample protection, workflow efficiencies, asset/cost optimization and regulatory compliance.

READ MORE

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE